(Q37609329)

21 August 2017

title

Quality of life in irritable bowel syndrome: measurement techniques and relevance of current knowledge (English)

1 reference

21 August 2017

1 reference

irritable bowel syndrome

1 reference

Magnus Simrén

1

1 reference

21 August 2017

publication date

1 February 2003

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

3

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

75-88

1 reference

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Predictors of health care seeking for irritable bowel syndrome: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Irritable bowel syndrome in general practice: prevalence, characteristics, and referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Quality of life in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Quality of life measurement in gastrointestinal and liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Standards for validating health measures: definition and content

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Non-colonic features of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

The McGill Pain Questionnaire: Major properties and scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.3.1.75

21 January 2018

Identifiers

DOI

10.1586/14737167.3.1.75

1 reference

21 August 2017

1 reference